|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/09 | (2006.01) |
| C12N 15/86 | (2006.01) | ||
| C12N 15/861 | (2006.01) | ||
| C07K 14/705 | (2006.01) | ||
| C07K 14/005 | (2006.01) | ||
| A61K 38/17 | (2006.01) | ||
| A61F 9/008 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 48/00 | (2006.01) | ||
| A61P 27/02 | (2006.01) |
| (11) | Number of the document | 3472317 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17814228.7 |
| Date of filing the European patent application | 2017-06-16 | |
| (97) | Date of publication of the European application | 2019-04-24 |
| (45) | Date of publication and mention of the grant of the patent | 2022-03-16 |
| (46) | Date of publication of the claims translation | 2022-06-27 |
| (86) | Number | PCT/US2017/038012 |
| Date | 2017-06-16 |
| (87) | Number | WO 2017/218981 |
| Date | 2017-12-21 |
| (30) | Number | Date | Country code |
| 201662351231 P | 2016-06-16 | US |
| (72) |
BLUMENKRANZ, Mark , US
GASMI, Mehdi , US
|
| (73) |
Adverum Biotechnologies, Inc. ,
800 Saginaw Drive, Redwood City, CA 94063,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kompozicijos ir būdai, skirti neovaskuliarizacijos akyse sumažinimui |
| COMPOSITIONS AND METHODS FOR REDUCING OCULAR NEOVASCULARIZATION |
| Payment date | Validity (years) | Amount | |
| 2025-05-23 | 9 | 208.00 EUR |
| 2026-06-16 |